Table 2.
Grade 1 | Grade 2 | Grade 3 | ||||
---|---|---|---|---|---|---|
| ||||||
N* | (95% CI) | N* | (95% CI) | N* | (95% CI) | |
Stage IA | ||||||
All patients | 8615 | 8.3% (7.7–8.9%) | 3627 | 5.0% (4.3–5.7%) | 761 | 4.7% (3.4–6.5%) |
<30 years | 236 | 20.3% (15.7–25.9%) | 96 | 12.5% (7.3–20.6%) | 14 | 7.1% (1.3–31.5) |
30–34 years | 630 | 14.3% (11.8–17.2%) | 25 | 8.8% (5.9–12.9%) | 40 | 7.5% (2.6–19.9%) |
35–39 years | 1296 | 12.2% (10.5–14.1%) | 556 | 7.2% (5.3–9.6%) | 84 | 8.3% (4.1–16.2%) |
40–44 years | 2400 | 8.6% (7.6–9.8%) | 940 | 4.4% (3.2–5.9%) | 1784 | 4.2% (2.2–8.1%) |
45–49 years | 4053 | 5.3% (4.6–6.0%) | 1784 | 3.7% (2.9–4.7%) | 434 | 3.9% (2.5–6.2%) |
Total patients (ovarian conservation and oophorectomy).